The research has found a lower antioxidant capacity of plasma in patients with Alzheimer’s disease and controls expressing the APOE genotype 4/4 without cognitive damage, but have not found a lower antioxidant capacity when the subjects performed cognitive tasks better [10]. This evidence concerns the gene APOE and Alzheimer disease.